Synthesis, kinetics, mechanisms, and bioactivity evaluations of a novel Zn(II) complex

Anwesha Dey,Ramesh Kumar,Bhramar Dutta,Rajib Bandopadhyay,Sankha Chakrabortty,Moonis Ali Khan,Rijuta Ganesh Saratale,Ganesh Dattatraya Saratale,Byong Hun Jeon,Alak K. Ghosh
DOI: https://doi.org/10.1039/d4ra03356f
IF: 4.036
2024-09-11
RSC Advances
Abstract:Zn( II )-based anticancer drugs can be suitable alternatives to conventional Pt( II )-based drugs because of the unique chemical properties of Zn( II ) and low toxicity. In this study, a new hexadentate and heteroleptic Zn( II ) complex ([Zn(bpy) 2 (OAc) 2 ], 1 ) was prepared with a conventional N , N -donor ligand (2,2′-bipyridine) and a leaving group (OAc) and characterized via ESI-MS, UV-Vis, and FT-IR spectroscopy. Kinetic and mechanistic investigations of 1 were performed using two biologically relevant ligands ( DL -penicillamine and L -cysteine) to understand its selectivity and reactivity. Substitution reactions were determined to be two-step processes in the associative activation mode. Bioactivity studies of 1 revealed moderate to strong DNA-binding, cleaving ability, and antimicrobial properties.
chemistry, multidisciplinary
What problem does this paper attempt to address?